Terapia Manipolativa Osteopatica e Sclerosi Multipla: uno studio proof-of-concept
AutoriChristian Cordano, MD, PhD, Annalisa Armezzani, DO; Jacopo Veroni, DO; Matteo Pardini MD, PhD; Davide Sassos, MD; Maria Teresa Infante, MD; Andrea Tacchino, PhD; Caterina Lapucci, MD; Maria Cellerino, MD; Valentina Calabrò, MD; Luigi Ciullo, DO; Bardia Nourbakhsh, MD, MAS.
Pubblicata sul Journal of American Osteopathic Association la ricerca scientifica sugli effetti del trattamento manipolativo osteopatico sui sintomi cronici della Sclerosi Multipla (SM) promossa e sostenuta dall’Istituto IEMO in Genova, insieme all’Università di Genova – Dipartimento di Neuroscienze, Riabilitazione, Oftamologia, Genetica e Salute Materna e Infantile, al Dipartimento di Neurologia della University of California e della Johns Hopkins University School of Medicine di Baltimore e, infine, alla Fondazione italiana Sclerosi Multipla di Genova.
Research on the effect of osteopathic manipulative therapy (OMTh; manipulative care provided by foreign-trained osteopaths) on chronic symptoms of multiple sclerosis (MS) is lacking.
To evaluate the effect of OMTh on chronic symptoms of MS.
Patients with MS who were evaluated at the neurology clinic at Genoa University in Italy were recruited for this study. Participants received 5 forty-minute MS health education sessions (control group) or 5 OMTh sessions (OMTh group). All participants completed a questionnaire that assessed their level of clinical disability, fatigue, depression, anxiety, and quality of life before the first session, 1 week after the final session, and 6 months after the final session. The Extended Disability Status Scale, a modified Fatigue Impact Scale, the Beck Depression Inventory-II, the Beck Anxiety Inventory, and the 12-item Short Form Health Survey were used to assess clinical disability, fatigue, depression, anxiety, and quality of life, respectively.
Twenty-two participants were included in the study (10 in the control group and 12 in the OMTh group). In the OMTh group, statistically significant improvements in fatigue and depression were found 1 week after the final session (P=.002 and P<.001, respectively). An increase in quality of life was also found in the OMTh group 1 week after the final session (P=.36).
Results demonstrate that OMTh should be considered in the treatment of patients with chronic symptoms of MS.
La pubblicazione tradotta in italiano è disponibile in Pdf in questa pagina.